Literature DB >> 8164680

Enhanced I kappa B alpha degradation is responsible for constitutive NF-kappa B activity in mature murine B-cell lines.

S Miyamoto1, P J Chiao, I M Verma.   

Abstract

Nuclear factor kappa B (NF-kappa B) is a ubiquitous transcription factor which binds to decameric DNA sequences (kappa B sites) and regulates transcription of multiple genes. The activity of NF-kappa B is regulated by an inhibitor protein, I kappa B, which sequesters NF-kappa B in the cytoplasm. Release of I kappa B and subsequent nuclear translocation of NF-kappa B generally require activating signals. However, in mature murine B cells, the DNA-binding activity of NF-kappa B is constitutively nuclear and activates the Ig kappa gene, a marker for mature B cells. To understand the basis for the constitutive NF-kappa B activation, we examined the properties of NF-kappa B and I kappa B in both pre-B and mature B cells, the regulated and constitutive states, respectively. We found that expression of I kappa B alpha and p105, members of the I kappa B family, and Rel, a member of the NF-kappa B family, is augmented in mature B cells. Both I kappa B alpha and p 105 are associated with NF-kappa B proteins and sequester most of these proteins in the cytoplasm of mature B cells. However, rapid I kappa B alpha dissociation and degradation lead to continuous nuclear translocation of a small fraction of NF-kappa B proteins, which represent the constitutively active NF-kappa B in mature B cells. We estimate that the protease activity is at least 35-fold greater in mature B cells than in pre-B cells. Rapid degradation of I kappa B alpha is directly involved in constitutive NF-kappa B activation, because stabilization of I kappa B alpha by a protease inhibitor causes loss of NF-kappa B activity in mature B cells. These results provide evidence that continuous and rapid degradation of I kappa B alpha in the absence pf external stimuli is causally involved in the constitutive activation of NF-kappa B in mature murine B cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8164680      PMCID: PMC358694          DOI: 10.1128/mcb.14.5.3276-3282.1994

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  46 in total

1.  The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-kappa B-mediated inhibition.

Authors:  G Franzoso; V Bours; S Park; M Tomita-Yamaguchi; K Kelly; U Siebenlist
Journal:  Nature       Date:  1992-09-24       Impact factor: 49.962

2.  Rapid induction in regenerating liver of RL/IF-1 (an I kappa B that inhibits NF-kappa B, RelB-p50, and c-Rel-p50) and PHF, a novel kappa B site-binding complex.

Authors:  M Tewari; P Dobrzanski; K L Mohn; D E Cressman; J C Hsu; R Bravo; R Taub
Journal:  Mol Cell Biol       Date:  1992-06       Impact factor: 4.272

Review 3.  NF-kappa B and Rel: participants in a multiform transcriptional regulatory system.

Authors:  M Grilli; J J Chiu; M J Lenardo
Journal:  Int Rev Cytol       Date:  1993

4.  NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway.

Authors:  S C Sun; P A Ganchi; D W Ballard; W C Greene
Journal:  Science       Date:  1993-03-26       Impact factor: 47.728

5.  Mutual regulation of the transcriptional activator NF-kappa B and its inhibitor, I kappa B-alpha.

Authors:  K Brown; S Park; T Kanno; G Franzoso; U Siebenlist
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

6.  p105 and p98 precursor proteins play an active role in NF-kappa B-mediated signal transduction.

Authors:  F Mercurio; J A DiDonato; C Rosette; M Karin
Journal:  Genes Dev       Date:  1993-04       Impact factor: 11.361

7.  The proto-oncogene bcl-3 encodes an I kappa B protein.

Authors:  L D Kerr; C S Duckett; P Wamsley; Q Zhang; P Chiao; G Nabel; T W McKeithan; P A Baeuerle; I M Verma
Journal:  Genes Dev       Date:  1992-12       Impact factor: 11.361

8.  The precursor of NF-kappa B p50 has I kappa B-like functions.

Authors:  N R Rice; M L MacKichan; A Israël
Journal:  Cell       Date:  1992-10-16       Impact factor: 41.582

9.  I kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: a mechanism for cytoplasmic retention.

Authors:  A A Beg; S M Ruben; R I Scheinman; S Haskill; C A Rosen; A S Baldwin
Journal:  Genes Dev       Date:  1992-10       Impact factor: 11.361

10.  The NF-kappa B p50 precursor, p105, contains an internal I kappa B-like inhibitor that preferentially inhibits p50.

Authors:  H C Liou; G P Nolan; S Ghosh; T Fujita; D Baltimore
Journal:  EMBO J       Date:  1992-08       Impact factor: 11.598

View more
  49 in total

1.  Postrepression activation of NF-kappaB requires the amino-terminal nuclear export signal specific to IkappaBalpha.

Authors:  T T Huang; S Miyamoto
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

2.  Regulation of constitutive p50/c-Rel activity via proteasome inhibitor-resistant IkappaBalpha degradation in B cells.

Authors:  Shelby O'Connor; Stuart D Shumway; Ian J Amanna; Colleen E Hayes; Shigeki Miyamoto
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

3.  Monoubiquitination of nuclear RelA negatively regulates NF-κB activity independent of proteasomal degradation.

Authors:  Karin Hochrainer; Gianfranco Racchumi; Sheng Zhang; Costantino Iadecola; Josef Anrather
Journal:  Cell Mol Life Sci       Date:  2012-01-20       Impact factor: 9.261

Review 4.  NF-κB addiction and its role in cancer: 'one size does not fit all'.

Authors:  M M Chaturvedi; B Sung; V R Yadav; R Kannappan; B B Aggarwal
Journal:  Oncogene       Date:  2010-12-20       Impact factor: 9.867

5.  Activation of the NF-kappa B and I kappa B system in smooth muscle cells after rat arterial injury. Induction of vascular cell adhesion molecule-1 and monocyte chemoattractant protein-1.

Authors:  D B Landry; L L Couper; S R Bryant; V Lindner
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

6.  NF-kappaB dictates the degradation pathway of IkappaBalpha.

Authors:  Erika Mathes; Ellen L O'Dea; Alexander Hoffmann; Gourisankar Ghosh
Journal:  EMBO J       Date:  2008-04-10       Impact factor: 11.598

7.  IkappaB is a substrate for a selective pathway of lysosomal proteolysis.

Authors:  A M Cuervo; W Hu; B Lim; J F Dice
Journal:  Mol Biol Cell       Date:  1998-08       Impact factor: 4.138

8.  Inhibition of c-myc expression induces apoptosis of WEHI 231 murine B cells.

Authors:  M Wu; M Arsura; R E Bellas; M J FitzGerald; H Lee; S L Schauer; D H Sherr; G E Sonenshein
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

9.  Clinically relevant findings.

Authors:  T D Gilmore
Journal:  J Clin Invest       Date:  1997-12-15       Impact factor: 14.808

10.  Novel IkappaB alpha proteolytic pathway in WEHI231 immature B cells.

Authors:  S Miyamoto; B J Seufzer; S D Shumway
Journal:  Mol Cell Biol       Date:  1998-01       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.